Granulocyte colony-stimulating factor accelerates neutrophil engraftment following peripheral-blood stem-cell transplantation: a prospective, randomized trial

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
T R KlumppJ S Macdonald

Abstract

It is well-established that the infusion of hematopoietic growth factors (HGF) accelerates neutrophil recovery in patients undergoing high-dose therapy followed by autologous bone marrow infusion. In addition, there is evidence that the infusion of autologous peripheral-blood stem cells (PBSC) accelerates engraftment in comparison to patients who receive bone marrow alone. However, few data are available regarding the ability of HGF to accelerate engraftment further in patients who receive PBSC following high-dose therapy. Forty-one patients undergoing high-dose therapy followed by infusion of autologous PBSC with or without bone marrow were randomized to receive granulocyte colony-stimulating factor (G-CSF) 5 micrograms/kg/d beginning on day + 1 following transplant or standard posttransplant supportive care without HGF. The median time to a neutrophil count > or = 500/microL was 10.5 days in the G-CSF group versus 16 days in the control group (P = .0001). G-CSF was associated with statistically significant reductions in the time to neutrophil engraftment among patients who received PBSC alone (11 v 17 days, P = .0003) and in patients who received PBSC in conjunction with bone marrow (10 v 14 days, P = .02). The median duratio...Continue Reading

Citations

May 10, 2002·Leukemia & Lymphoma·M A SlavinA W Roberts
Dec 18, 2009·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Meghana TrivediEdward D Ball
Jan 1, 1997·Vox Sanguinis·M J Watts, D C Linch
Oct 3, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·I DebrixA Beker
Jul 3, 1997·International Journal of Cancer. Journal International Du Cancer·Y YamadaS Kamidono
Apr 20, 2001·Paediatric Drugs·L M Wagner, W L Furman
Feb 22, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·P H ChandrasekarR Baynes
Jun 29, 2001·Transplant Infectious Disease : an Official Journal of the Transplantation Society·K A Marr, R A Bowden
Sep 27, 2003·British Journal of Haematology·Antonio PagliucaUNKNOWN Haemato-Oncology Task Force of the British Committee for Standards in Haematology
Jun 1, 2002·Bone Marrow Transplantation·J HornedoUNKNOWN SOLTI Group
Sep 25, 2002·Drugs·Hulya Ulukan, Peter W Swaan
Sep 27, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Francesc Fernández-AvilésEmili Montserrat
Aug 21, 2010·Transfusion·Laura SchlahsaConstança Figueiredo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Related Papers

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
W I BensingerC D Buckner
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
G SpitzerW McIntyre
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
W I BensingerC H Weaver
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
P J BiermanJ O Armitage
© 2021 Meta ULC. All rights reserved